Optimum Large Cap Growth C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Optimum Large Cap Growth Fund Class C OCLGX
- NAV / 1-Day Return 12.50 / −0.56 %
- Total Assets 1.9B
-
Adj. Expense Ratio
1.950%
- Expense Ratio 1.960%
- Distribution Fee Level High
- Share Class Type Level Load
- Category Large Growth
- Investment Style Large Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 54%
USD | NAV as of Jun 10, 2026 | 1-Day Return as of Jun 10, 2026, 12:11 AM GMT+0
Morningstar’s Analysis OCLGX
Will OCLGX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the OCLGX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of OCLGX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 58.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
NVIDIA Corp | 14.92 | 281M | Technology |
Apple Inc | 10.01 | 189M | Technology |
Microsoft Corp | 7.08 | 133M | Technology |
Alphabet Inc Class A | 5.19 | 98M | Communication Services |
Amazon.com Inc | 5.18 | 98M | Consumer Cyclical |
Broadcom Inc | 4.55 | 86M | Technology |
Alphabet Inc Class C | 4.35 | 82M | Communication Services |
Meta Platforms Inc Class A | 2.96 | 56M | Communication Services |
Tesla Inc | 2.63 | 50M | Consumer Cyclical |
Eli Lilly and Co | 1.99 | 37M | Healthcare |
United States